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Abstract: This paper characterizes in an in vitro setting the release of calcium (Ca) and phosphate
(PO4) of 3D printed bioactive ceramic scaffold prepared from extrudable paste containing
hydroxyapatite and β-tricalcium phosphate (β-TCP). Hydroxyapatite and β-TCP were calcined at
800 ℃ for 11 h, fabricated into four experimental groups (100% HA, 100% β-TCP, 15%/85%
HA/β-TCP, and 15%/85% HA/β-TCP (design)), sintered to 1100 ℃ for 4 h. Calcium and phosphorus
concentrations were evaluated using ICP spectroscopy, and the release of Ca and PO4 ions during
dissolution of the CaP-based scaffolds was measured by submerging in 0.05 mol/L
Tris(hydroxymethyl)aminomethane-HCl and maintaining a temperature of 37 ℃. The Ca and PO4
concentrations of the solutions were measured with the utilization of a calcium assay kit and a
phosphate assay kit and read in a UV–visible spectrophotometer. The 100% HA scaffold group
showed the greatest concentration of Ca ions (~1.9 mg/dL), but ultimately released at a lower amount
as time increased; the 100% HA scaffold also showed the lowest total amount of calcium ions released
over the course of evaluation. The results for the 100% β-TCP were on the opposite of the HA with
the highest amount of calcium ion release over the study. While the PO4 ion release showed a similar
trend as those observed with Ca ions with an apparent difference in the 100% HA scaffold group.
There was nearly 0 mg/dL of the phosphate ions released in the first 24 h, in comparison to the
amount of Ca ions released during the same time frame. Since various formulations can lead to
different properties of these bioactive ceramic scaffolds, it is important to understand how the
tailoring of this important biphasic material can impact the long-term outcome of an ever-important in
vivo clinical trial in the future.
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Introduction

Bone wound healing is a complicated area of research,

* Corresponding author.
E-mail: lukasz.witek@nyu.edu

which has doctors, engineers, and scientists
continuously searching for the most appropriate
solutions. Currently there are no “ideal” options on the
market to repair large, critical sized defects or load
bearing areas. The future of bone grafting is leading
towards the combination of materials and fabrication
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processes, which will allow for fabrication of
“tailor-able” devices.
The repair of critical sized long bone defects is of
special interest in the orthopedic field due to its
reconstructive complexity. Much attention has been
given to the defect site’s blood supply, with focus
between bone and immune cells and mechanical
reestablishment. Most commonly, the defects are
caused by birth defect, trauma, or tumor resection.
These issues may leave the patient with a critical sized
defect, which must be controlled with suitable dead
space management followed by bone reconstruction
utilizing a grafting material or device, which is
osteoconductive and degradable, while simultaneously
minimizing complications and shortening the duration
of recovery.
Currently, the viable bone grafting material solution
is calcium phosphate (CaP)-based, which possesses two
(osteoconduction and osseointegration) of the
following three properties: osteoconduction—the
capability to support the growth of bone over its surface;
osteogenesis—the process of extra cellular matrix
deposition and subsequent mineralization by
osteoblasts; and osseointegration—the ability to
intimately interact with bone without an extra layer of
soft tissue. However, different host-to-grafting material
responses have been reported and should be taken into
consideration while determining treatment options.
The stability of calcium phosphate-based ceramics is
known to be compositionally and structurally dependent
[1], depending on the materials hydroxyapatite (HA),
beta tri-calcium phosphate (β-TCP), or biphasic
calcium phosphate (BCP). When these CaP-composed
devices are implanted, the ceramic will undergo
dissolution at different rates (HA < β-TCP < α-TCP)
[2,3]. Additionally, when placed in vivo, the CaP
ceramics induce a precipitation of a phase which is
comparable to the HA-like mineral found in bone [4].
While in some instances it has been seen that a bone
apatite-like material was formed in nonosseous sites
[3,4]. Therefore, an important factor with regards to
bioactivity (bone tissue formation rate and bone tissue
bonding) is the release of ions from the dissolution of
CaP ceramics, which in turn may affect cellular activity,
organic matrix deposition, or mineral deposition [5,6].
There was an analysis and assessment of the
dissolution of 3D printed lattice-based bioactive
ceramic scaffolds (LBBCS) [7]. In an in vitro setting, it
is of value to qualitatively and quantitatively analyze
and observe any possible phase changes, which can

possibly occur during the fabrication process or
dissolution process [8,9]. In the past, there has been
work done to try to interpret as well as predict the
long-term effects of the dissolution of CaP ceramics.
This study is set out to determine the relative
dissolution behavior of four experimental groups (Table
1) specifically the mean concentrations (mg/dL) of Ca
and PO4 ions which were released from the 3D printed
grafting
devices
in
a
Tris(hydroxymethyl)
aminomethane-HCl buffer environment [4].

2 Materials and methods
2. 1

Ink preparation

Prior to 3D printing, the formulated colloidal gel was
subjected to a series of powder processing steps at the
beginning (e.g., calcining, attrition milling, and drying
of the individual base materials), which is described in
detail by Witek et al. [7]. The aforementioned
processed ceramic powders were utilized for the
colloidal ink suspension, with a solid volume fraction
( solid ) of approximately 46% ceramics, (i.e., 100% HA
(0.7 μm in particle size), 100% β-TCP (0.4 μm in
particle size), or pre-determined ratio of HA:β-TCP)
[10]. Upon calculating the appropriate amounts of
ceramic powders, H2O, and dispersant, Darvan®821A
(R.T. Vanderbilt Company, Inc., Norwalk, CT, USA),
~15 mg/g of ceramic, the materials were added to a
mixing container in which the bottom was charged with
zirconia milling media (5 mm; Union Process, Akron,
OH, USA). The mixture was spun in a conditioning
mixer (THINKY AR-250; Thinky, Tokyo, Japan) for
180 s at 2000 rpm. The next step was the addition of a
thickening agent, Methylcellulose F4M (Dow Chemical
Company, Midland, MI, USA), approximately
8 mg/mL of ceramic, followed by spinning for ~120 s at
2000 rpm. The final step was the addition of a gelling
mechanism (polyethlyenimine (PEI); Sigma-Aldrich St.
Louis, MO, USA). About 200 mg of polyethyleneimine
per 30 mL of ink was added followed by spinning to
achieve the desired consistency.
After the colloidal gel was prepared, it was 3D
printed into circular lattice scaffolds (Fig. 1).
Table 1 Summary of the four primary experimental
scaffold groups used for the in vitro dissolution evaluation
of Ca and PO4 release over a set amount of time
Group
1
2
3
4
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Description
100% HA
100% β-TCP
15%/85% HA/β-TCP
15%/85% HA/β-TCP(design)

Abbreviation
HA
β-TCP
BCP
BCP (design)
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such as cracking and warping [10]. The sintering
shrinkage of ceramics is an unavoidable step, and all
dimensions of the designed geometric structure must be
enlarged to account for this phenomena and to
ultimately attain the final desired dimensions.
2. 3 Chemical characterization

Fig. 1 Schematic of scaffold designed in RoboCAD 4.3
(3D Inks, LLC Tulsa, OK, USA): (a) isometric view, (b)
top view, (c) front/side view, and (d) final scaffold after
sintering.

2. 2 Sample fabrication
The 3D direct-writing printer used a gantry robot with
affixed syringe pumps to extrude the colloidal inks
through a fine nozzle to build the 3D scaffold [11,12].
The 3D disc-shaped scaffolds (10 mm in diameter,
~2 mm in thickness, 330 μm in struts, and 500 μm in
pore size) were designed on a computer-aided design
(CAD) software (RoboCAD 4.3, 3D Inks, LLC Tulsa,
OK, USA) (Fig. 1). The 3D disc-shaped scaffolds were
printed layer-by-layer at 10 mm/s deposition rate onto a
flat ceramic substrate (ADS-96R, Coors Tek, Grand
Junction, CO, USA) in low-viscosity paraffin oil
(Ultra-Pure lamp oil, Lamplight Farms Inc.,
Menomonee Falls, WI, USA) to prevent drying of the
structure during assembly.
After the scaffolds were fabricated, they were
removed from the oil bath and allowed to dry in air for
~12 h prior to the sintering process. Heat treatment of
the scaffolds was performed utilizing an electric furnace
(Model LHT 02/17, Nabertherm GmbH, Lilienthal,
Germany) to enhance the mechanical strength for
handling during the experiments (e.g., in vitro
dissolution study) [11]. During the sintering processing,
the green body ceramics were densified and organic
components were burned off. The firing protocol began
by heating at 2 ℃/min until 400 ℃, dwelling at 400 ℃
for 2 h, then heating until 900 ℃ (~8 ℃/min), dwelling
for 2 h at 900 ℃, heating at 3.3 ℃/min to ultimate
temperature of 1100 ℃, dwelling at 1100 ℃ for 4 h, and
finally cooling at ~8.0 ℃/min until the samples were
cooled to room temperature (~30 ℃). The binder
burnout during the sintering process resulted in a
predictable volumetric shrinkage (~20%) and defects

Calcium (Ca) and phosphorus (P) concentrations were
evaluated using inductively coupled plasma (ICP)
spectroscopy (Thermo Jarell Ash, Trace Advantage,
Franklin, MA, USA). For this objective, 10 mg of
powders from each experimental group were dissolved
in 35% HCl solution and mixed 100 mL of double
distilled water in a volumetric flask. Suitable standard
solutions for Ca (0, 20, and 40 ppm) and P (0, 10, and
40 ppm) were prepared from 100 ppm standard
solutions of the respective elements (Fisher Scientific,
Pittsburgh, PA, USA). Each specimen in solution and
standard solution was pumped through argon plasma,
which was excited by a 2 kW, 27.12 MHz radio
frequency generator [13]. Additionally scaffold groups
were subjected to energy-dispersive X-ray spectroscopy
(Hitachi S-4800, Schaumburg, IL, USA) for further
verification of their respective Ca:P ratios.
X-ray diffraction (XRD; Bruker AXS D8 Discover,
Madison, WI, USA) was used to determine the
crystalline phases present within the raw materials and
experimental groups. Three different spectra from each
testing group were obtained (n = 3 per group). The
diffractometer was operated by using a curved crystal
monochromator, operating at 45 mA and 45 kV, and
scanned in 2θ range from 20° to 65° [7], with a step size
of 0.02° at 3 s/step.
Rietveld refinement analysis used the data collected
from X-ray diffraction, and subsequently converted
data to “.xy” format. The raw data was then input into
Material Analysis Using Diffraction (MAUD) software
for quantitative analysis. Rietveld analysis utilized the
samples from previous XRD spectra (i.e., peak, height,
width, and position). This refinement method was used
to quantify the percentage of each phase (HA, β-TCP,
and other commonly observed phases in calcium- and
phosphate-based materials such as calcium oxide, CaO)
present in different calcination temperatures and
sintering groups. A least-squares fit approach was
utilized to measured scans until replicating a theoretical
scan (based on the structure in Inorganic Crystal
Structure Data Base (ICSD)) [14,15]. The background,
cell parameters, preferred orientation, peak asymmetry,
atomic positions, site occupancy factors, and global
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vibrational parameters were refined.
The in vitro observation for the release of Ca and PO4
ions during dissolution of the CaP-based scaffolds, was
measured by submerging LBBCS in a 24 well plate
(Corning® Costar®, Sigma-Aldrich, St. Louis, MO,
USA) (n = 1 scaffold/well) containing 0.05 mol/L
Tris(hydroxymethyl)aminomethane-HCl (bioWORLD,
Dublin, OH, USA) solution with a pH of ~7.3 and
maintaining a temperature of 37 ℃ (in an incubator).
The weight of scaffold to volume of solution ratio was
~1 mg/mL as recommended by Ducheyne et al. [4]. The
time periods to be examined for the release of ions was
from 1 h ranging to 2 weeks, with samples measured in
triplicate for each time point. The Ca and PO4
concentrations of the solutions were measured with the
utilization of a calcium assay kit (QuantiChromTM
Calcium Assay Kit (DICA-500), BioAssay Systems,
Hayward, CA, USA) and a phosphate assay kit
(Malachite Green Phosphate Assay Kit (POMG-25H),
BioAssay Systems, Hayward, CA, USA), read in a
UV–visible spectrophotometer (Cary 5000 UV-Vis-NIR,
Santa Clara, CA, USA).

scaffolds of 100% HA, 100% β-TCP, and 15%/85%
HA/β-TCP. The Ca/P ratios observed for the different
groups are similar to what is expected aside from 100%
HA, which seems to be slightly on the lower end of the
atomic value of ~1.67 (Fig. 2(b)). The EDS was done as
a supplemental quantitative verification measurement
on the primary sample groups. These values are taken as
an estimate of final average of the groups.
XRD spectra were collected of the individual raw
materials for crystalline verification. Their spectra were
matched to the theoretical HA and β-TCP. After
confirmation of the materials was complete, and the
experimental colloidal gels were fabricated and
subjected to sintering at 1100 ℃, XRD spectra were
obtained from the groups for crystalline phase
determination and verification (Fig. 3(a)). The β-TCP
phase is indicated by three high intensity peaks located

2. 4 Statistical analysis
For statistical evaluation, analysis of variance (ANOVA)
at a 95% confidence interval by using IBM SPSS v23
(IBM Corporation, Armonk, New York, USA) was
utilized considering HA and β-TCP ratios as
independent variables, thus Ca:P ratio and Ca and PO4
ion concentrations were considered as dependent
variables.

3 Results
The ICP results were used to verify the Ca:P ratio of the
two individual materials, in each of the 3 experimental
states: (i) raw (as received), (ii) after calcination
(800 ℃), and (iii) post sintering (1100 ℃) (Fig. 2(a)).
The trend in the β-TCP group shows an initial decrease
from raw state to after calcination state, but then an
increase in post sintering state. The Ca:P ratio slightly
increases while going from raw, to calcined, and
ultimately sintered state in the HA group. The one-way
ANOVA statistical analysis results in p = 0.0204 and
p = 0.022, for HA and β-TCP respectively, indicating
significant effect due to the state of the material.
Energy-dispersive X-ray spectroscopy (EDS) was
completed to evaluate the Ca/P ratio for experimental

Fig. 2 (a) Mean ± 95% confidence intervals for Ca/P ratio
depicting the two primary groups (HA and β-TCP) and
their state. (b) Mean ± 95% confidence intervals for Ca/P
ratio of the experimental groups.
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Fig. 3 (a) Percentage of each phase of the as-received raw materials prior to calcination (β-TCP vertical filled bars, calcium
pyrophosphate (Ca Pyro) in hatched bars, and calcium oxide represented in horizontal filled bars). (b) The XRD spectra are a
comparison between the two basic components of the ink. The upper box represents the XRD spectrum of hydroxyapatite (HA)
group while the lower box represents the β-TCP group. A few of the most intense diffraction peaks are shown.

at 27.9°, 31.2°, and 34.4°, while the highest peaks for
HA are 31.8° and 32.9° (Fig. 3(b)). High crystallinity is
indicated by the narrow diffraction peaks described as
sharp peaks. This result is in good agreement with other
researchers’ works that found that biphasic mixing on a
crystallite level is feasible [16–18].
The calcium (Ca) and phosphate (PO4)
concentrations (mg/dL) of scaffold dissolution in
Tris-HCl solution are summarized in Table 2. Figure 4
indicates that the data, which begin at time point of 0 h
to indicate the initial, are used for analysis of both
calcium and phosphate. The 100% HA scaffold group
shows the greatest concentration of Ca ions
(~1.9 mg/dL), but ultimately releases at a lower amount,
which can be seen at hour 336 (day 14). The 100% HA
scaffold has the lowest amount of calcium ions released.

On the other end of the materials, the 100% β-TCP has
the highest concentration released with approximately a
measurement of 7.6 mg/dL. The 15%/85% HA/β-TCP
scaffold group falls in between the 100% HA and 100%
β-TCP groups, and at day 14 has a Ca ion release of
approximately 5.95 mg/dL.
While the PO4 ion release shows a similar trend as
that in Ca with one apparent difference in the 100% HA
scaffold group. There is nearly 0 mg/dL of the
phosphate ion released in the first 24 h, in comparison
to the amount of Ca ions released during the same time
frame. The 100% HA group eventually ends up having
a release of approximately 5.1 mg/dL at day 14, but it is
short of what the other three groups (100% β-TCP,
15%/85% HA/β-TCP, and 15%/85% HA/β-TCP
(design)) release in the same time period. 100% β-TCP,

Table 2 Ca and PO4 mean concentration as released from the mono- and bi-phasic scaffold groups; the standard
deviations are noted in parentheses
(Unit: mg/dL)
Group

Element
2+

Ca
HA

(PO4)3
Monophasic
Ca2+
β-TCP
(PO4)3
Ca2+
HA/β-TCP
(PO4)3
Biphasic
HA/β-TCP
(design)

Ca2+
(PO4)3

1
1.864
(0.13)
0.079
(0.06)
1.485
(0.08)
1.304
(0.18)
1.044
(0.03)
1.099
(0.13)
0.770
(0.03)
1.056
(0.05)

12
1.971
(0.24)
0.089
(0.09)
2.015
(0.31)
1.636
(0.14)
1.318
(0.08)
1.788
(0.23)
0.914
(0.04)
1.830
(0.08)

24
2.015
(0.04)
0.108
(0.05)
2.256
(0.28)
1.939
(0.03)
1.606
(0.13)
2.367
(0.36)
1.215
(0.01)
2.468
(0.26)
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Time (h)
72
168
3.874
2.463
(0.05)
(0.62)
0.952
2.112
(0.00)
(0.17)
5.250
5.675
(0.76)
(0.15)
4.265
7.183
(0.44)
(0.19)
3.601
4.245
(0.38)
(0.03)
4.659
6.685
(1.29)
(0.48)
2.555
3.465
(0.03)
(0.14)
4.752
7.373
(0.48)
(0.57)

216
3.659
(0.48)
2.284
(0.04)
6.129
(0.31)
7.525
(1.59)
4.621
(0.62)
8.097
(0.06)
3.426
(0.26)
8.097
(0.59)

288
4.540
(0.31)
3.882
(0.75)
7.349
(0.23)
7.912
(0.34)
5.510
(0.16)
8.496
(0.91)
4.038
(0.27)
8.221
(0.72)

336
4.469
(0.04)
5.112
(0.59)
7.632
(0.65)
7.912
(1.01)
5.947
(0.16)
8.581
(0.34)
4.437
(0.16)
9.346
(0.92)
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Fig. 4 (a) Ca concentration and (b) PO4 concentration in
0.05 mol/L Tris buffer after immersion of 100% HA, 100%
β-TCP, 15%/85% HA/β-TCP, and 15%/85% HA/β-TCP
(design) for time periods ranging from 1 to 336 h (14 days).

15%/85% HA/β-TCP, and 15%/85% HA/β-TCP (design)
follow the same trend, and at day 14, they all have an
average PO4 ion concentration of ~8.61 mg/dL, with no
significant difference between these three experimental
scaffolds’ compositions. Additionally, the experimental
scaffolds’ compositions were analyzed after the time in
vitro, to verify no changes in phases. As seen in Figs.
5(a)–5(d), when evaluating the relevant peaks, no
differences are observed from time 0 thru 28 days,
indicating that the material remains unaffected over
time.

4

Discussion and conclusions

Being that a wide range of physical and chemical
properties can be achieved with this particular bioactive
ceramic by modifying specific parameters, such as the

Fig. 5 These XRD spectra are for groups (a) 100% HA,
(b) 100% β-TCP, (c) 15%/85% HA/β-TCP, and (d)
15%/85% HA/β-TCP (design) and are a comparison among
the six time points in vitro: (i) initial, (ii) 1 day, (iii) 7 days,
(iv) 14 days, (v) 21 days, and (vi) 28 days.

HA/β-TCP ratio, calcining and/or sintering temperature
[19], these materials have been used to fabricate
pre-formed implants and have shown considerably
greater mechanical strength in comparison to other
bioceramics used for similar bone grafting purposes
[19]. The present study aimed to chemically
characterize bioactive ceramic LBBCS prepared as
100% HA, 100% β-TCP, 15%/85% HA/β-TCP, and a
model 15%/85% HA/β-TCP group with raw materials
calcined at 800 ℃, and final LBBCS subjected to a
sintering regimen of 1100 ℃.
The advantage of this material, which is fabricated to
an aqueous paste, allows for fabrication of scaffolds
utilizing solid free form (SFF) equipment also known as
robocasting. This 3D printing technique allows for the
production of variety of complex structures utilizing
CAD/CAM software in addition to utilizing computed
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tomography scans exported to a specific file type which
can in turn be fabricated to a specific defect, capable of
reproducing the same structure consistently [20].
XRD of the as-received materials prior to calcination
primarily showed HA and β-TCP crystalline phases for
the individual HA and β-TCP powders. However, phase
quantification through Rietveld refinement showed
trivial fractions of β-TCP, calcium pyrophosphate
(Ca2P2O7), and calcium oxide (CaO) for the HA
as-received material, and minor fractions of HA,
Ca2P2O7, and CaO for the β-TCP starting material.
Given that the aqueous pastes were fabricated without
considering the presence of minor quantities of other
CaP-based phases, the intended composition of the
15%/85% HA/β-TCP group was slightly shifted from
what was originally intended.
Phosphorus (P) is widely distributed in the body.
More than 80% of total phosphate (PO4) is present in
the bone and teeth in the form of apatite. The remaining
phosphate is mostly present in the skeletal muscle, with
trace amounts in the extracellular fluids (< 0.1%)
[21–24]. Intracellular phosphate ions are essential for
oxidative phosphorylation and approximately 20% of
cellular phosphate is present in the mitochondria.
Roughly 30% of total cellular phosphate is stored in the
endoplasmic reticulum and is used in phosphorylation
of various proteins. The remaining cellular phosphate is
present in the nucleus, Golgi complex, and lysosomes.
Transporting phosphate in and out of the cell according
to the need of the body is a complex process and the
exact molecular mechanisms of such sensitive transport
are not entirely clear. It is important to note that cells
use PO4 to transport cellular energy through the
formation of ATP by oxidative phosphorylation.
With the aforementioned, phosphorus is an essential
nutrient for the body and is routinely consumed through
food. After consumption, phosphorus binds with
oxygen and exists as PO4 in the body. Both organic and
inorganic forms of PO4 are present in regularly
consumed foods. The amount of total PO4 ingestion can
be significantly influenced by consumption of
processed food and beverage, as there are phosphate
metabolites additives in these items. Following a meal,
inorganic phosphate can be rapidly absorbed across the
small intestine and enter the blood stream causing an
elevation in blood phosphate levels. The net efficiency
of intestinal phosphate absorption is double that of Ca
[25]. Taking into consideration just the amount of
phosphate consumed and adding a calcium phosphate
(CaP)-based scaffold can lead to a potential toxic

situation. Phosphate toxicity due to excessive retention
of PO4 in the body can cause a variety of cellular and
tissue damage. An example is seen with the higher
occurrence of vascular calcification, encountered in
patients with chronic kidney disease, is related to the
increased retention of phosphate in the body [26,27].
The normal range of PO4 should be in the order of
2.4–4.1 mg/dL, so this is of importance as when
scaffold is placed in the system, the levels in the local
region may be slightly higher than normal, but should
not increase the overall levels to prevent any
complications such as cell death, which in turn would
lead to killing new bone cells.
Chen et al. [28] and Sweet et al. [29] have studied
the in vitro analysis of ion release in the SBF solution,
with regards to cytotoxicity. The cytotoxicity assay
results indicated that the 100% β-TCP material, which
is most commonly used, did not have a negative effect
on altering the Schwann cells in vitro.
The data from the in vitro portion of this study is in
agreement with literature. Using the 100% HA and
100% β-TCP as controls and the two 15%/85%
HA/β-TCP groups as the experimental groups, the
results are similar to what was expected. Literature
presents the bulk or pressed powder properties of these
two control group materials, but does not present the
biphasic mixture release for Ca or PO4 in an in vitro
setting. The results indicate the trend for the two
biphasic groups, in which the rates of calcium and
phosphate ion release should fall above the 100% HA
but below 100% β-TCP. This was the result, which was
observed when doing a qualitative analysis of the
results and further identified with the extrapolation of
data from previous bulk property results.
Overall, since various chemical formulations can
lead to different physiochemical properties of these
extruded materials processed, it is important to
understand how the tailoring of this important biphasic
material can impact the long-term outcome of an
ever-important in vivo clinical trial in the future.
As the scaffolds can be fabricated from mixing
various ratios of the bioactive ceramic, HA and β-TCP,
both of which are biocompatible, resorbable, and can
facilitate in the regeneration and remodeling of bone at
defect site, the results are important on how to tailor
composition. Custom ratios of the materials in scaffolds
for use in load and non-load bearing models are
warranted to explore the rate of osseointegration, as the
release of these ions has the potential to dictate which
material would be of use in the final scaffold design.
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